Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
TLSA
Stock Latest News
Company Announcements
Tiziana Life Sciences Completes Enrollment in Phase 2 INFORM-MS Trial for Intranasal Foralumab
16d ago
6K
TLSA
Premium
The Fly
Tiziana Life Sciences doses last patient in intranasal foralumab trial
16d ago
TLSA
Premium
The Fly
Tiziana Life Sciences chairman Gabriele Cerrone purchases 15,000 shares
26d ago
TLSA
Premium
Company Announcements
Tiziana Life Sciences Chair Boosts Stake as Foralumab Trials Advance
26d ago
6K
TLSA
Premium
The Fly
SpaceX targets IPO valuation of at least $1.8T, Bloomberg says
1M ago
TLSA
Premium
Company Announcements
Tiziana Life Sciences to Showcase Intranasal Foralumab Progress at Jefferies Healthcare Conference
1M ago
6K
TLSA
Premium
Company Announcements
Tiziana Life Sciences Completes Enrollment in Phase 2 Intranasal Foralumab MS Trial
2M ago
6K
TLSA
Premium
The Fly
Tiziana fully enrolls Phase 2 placebo-controlled MS trial
2M ago
TLSA
Premium
The Fly
Tiziana Life Sciences announces updated intranasal foralumab data
2M ago
TLSA
Premium
Company Announcements
Tiziana Life Sciences Reports Positive Expanded Access Data for Intranasal Foralumab in Progressive MS
2M ago
6K
TLSA
Premium
The Fly
Tiziana Phase 2 trial for foralumab shows reduced brain inflammation
2M ago
TLSA
Premium
Company Announcements
Tiziana Life Sciences Posts Early PET Data Showing Reduced Brain Inflammation in MSA Trial of Intranasal Foralumab
2M ago
6K
TLSA
Premium
Company Announcements
Tiziana Life Sciences Delays Annual 20-F Filing
2M ago
TLSA
Premium
The Fly
Tiziana Life announces publication of preclinical data in bioRxiv preprint
3M ago
TLSA
Premium
Company Announcements
Tiziana Life Sciences Highlights Preclinical Long COVID Brain Fog Data for Intranasal Foralumab
3M ago
6K
TLSA
Premium
Company Announcements
Tiziana Life Sciences’ Intranasal Foralumab MSA Trial Highlighted in Late-Breaking Poster at 7th World Parkinson Congress
3M ago
6K
TLSA
Premium
Company Announcements
Tiziana Life Sciences Reports Positive Preclinical Data for Nasal Anti-CD3 in Age-Related Cognitive Decline
3M ago
6K
TLSA
Premium
Company Announcements
Tiziana Life Sciences Posts Positive Biomarker Data for Intranasal Foralumab in Progressive MS
5M ago
6K
TLSA
Premium
The Fly
Tiziana Life Sciences announces new data on nasal foralumab
5M ago
TLSA
Premium
Company Announcements
Tiziana Life Sciences’ Intranasal Foralumab MS Study Published in Leading Neurology Journal
6M ago
6K
TLSA
Premium
The Fly
Tiziana Life Sciences announces publication of intranasal foralumab results
6M ago
TLSA
Premium
Company Announcements
Tiziana Life Sciences Raises $8.8 Million in Oversubscribed Direct Offering to Fund Phase 2 Trials
6M ago
6K
TLSA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
